Latest filing published 05 May 2017 for Moleculin Biotech, Inc., €747.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +123.4%Entry US$36,454.37 · Close at T+365 US$81,449.72
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jacqueline Northcut: trading record in brief
Our data holds just one disclosure by Jacqueline Northcut, dated 5 May 2017, reporting an open-market purchase worth €747 in Moleculin Biotech, Inc. Further filings will be added here. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jacqueline Northcut
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000 shares@ US$0.82100.0% of flowCommon StockSEC:0001144204-17-024864:0Canonical exit: 3 Aug 2017 (T+90)
1 of 1 declaration
